Viking Therapeutics, Inc. (0VQA.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.97B |
| Enterprise Value | 3.8B |
| P/E Ratio | -5.27 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.7 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.64 |
| Return On Equity | -1.17 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -431,000 |
| EBITDA | -392.91M |
| Net Income | -359.64M |
| Diluted EPS | -3.19 |
| Total Cash | 959.81M |
| Total Cash/Share | 8.13 |
| Total Debt | 254.69M |
| Total Debt/Equity | 0.43 |
| Current Ratio | 7.27 |
| Book Value Per Share | 4.99 |
| 52-Week Change | -27.84 |
| 52-Week High | 45.9 |
| 52-Week Low | 23.93 |
| Moving Average 50 Days | 29.59 |
| Moving Average 200 Days | 32.17 |
| Average Volume | 26,171 |
| Shares Outstanding | 127.52M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |